YU43010B - Process for obtaining new derivatives of 3-(1-piperidinylalkyl)-4h-pyrido /1,2a-/ pyrimidine-4-ones - Google Patents

Process for obtaining new derivatives of 3-(1-piperidinylalkyl)-4h-pyrido /1,2a-/ pyrimidine-4-ones

Info

Publication number
YU43010B
YU43010B YU810/81A YU81081A YU43010B YU 43010 B YU43010 B YU 43010B YU 810/81 A YU810/81 A YU 810/81A YU 81081 A YU81081 A YU 81081A YU 43010 B YU43010 B YU 43010B
Authority
YU
Yugoslavia
Prior art keywords
piperidinylalkyl
pyrido
pyrimidine
ones
obtaining new
Prior art date
Application number
YU810/81A
Other languages
English (en)
Other versions
YU81081A (en
Inventor
L E Kennis
J C Mertens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of YU81081A publication Critical patent/YU81081A/xx
Publication of YU43010B publication Critical patent/YU43010B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
YU810/81A 1980-03-28 1981-03-27 Process for obtaining new derivatives of 3-(1-piperidinylalkyl)-4h-pyrido /1,2a-/ pyrimidine-4-ones YU43010B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13484580A 1980-03-28 1980-03-28
US06/191,632 US4342870A (en) 1980-03-28 1980-09-29 Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives

Publications (2)

Publication Number Publication Date
YU81081A YU81081A (en) 1983-12-31
YU43010B true YU43010B (en) 1989-02-28

Family

ID=26832744

Family Applications (1)

Application Number Title Priority Date Filing Date
YU810/81A YU43010B (en) 1980-03-28 1981-03-27 Process for obtaining new derivatives of 3-(1-piperidinylalkyl)-4h-pyrido /1,2a-/ pyrimidine-4-ones

Country Status (22)

Country Link
US (1) US4342870A (cs)
EP (1) EP0037265B1 (cs)
AU (1) AU537700B2 (cs)
BG (1) BG36199A3 (cs)
CA (1) CA1163994A (cs)
CS (1) CS256366B2 (cs)
DE (1) DE3168433D1 (cs)
DK (1) DK159390C (cs)
ES (1) ES500814A0 (cs)
FI (1) FI71737C (cs)
GR (1) GR72488B (cs)
HU (1) HU187329B (cs)
IE (1) IE51319B1 (cs)
IL (1) IL62494A (cs)
MA (1) MA19107A1 (cs)
NO (1) NO156752C (cs)
NZ (1) NZ196522A (cs)
PH (1) PH16530A (cs)
PT (1) PT72740B (cs)
RO (1) RO82508A (cs)
SU (1) SU1068037A3 (cs)
YU (1) YU43010B (cs)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443451A (en) 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
US4548938A (en) * 1981-07-15 1985-10-22 Janssen Pharmaceutica N.V. 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds
US4355037A (en) * 1981-11-12 1982-10-19 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidyl)-1,2-benzisoxales
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4581171A (en) * 1983-07-27 1986-04-08 Janssen Pharmaceutica, N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
US4695569A (en) * 1983-11-30 1987-09-22 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines
US4888426A (en) * 1983-11-30 1989-12-19 Janssen Pharmaceutica N.V. 1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4548939A (en) * 1984-10-01 1985-10-22 Janssen Pharmaceutica N. V. 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
SG47757A1 (en) * 1986-09-22 1998-04-17 Janssen Pharmaceutica Nv Serotonin antagonists for treating wounds
IL90879A0 (en) * 1988-09-02 1990-02-09 Janssen Pharmaceutica Nv 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them
CA2000786C (en) * 1988-11-07 1999-01-26 Janssen Pharmaceutica, Naamloze Vennootschap 3-piperidinyl-1,2-benzisoxazoles
HU207310B (en) * 1988-12-02 1993-03-29 Pfizer Process for producing aryl-piperidine derivatives
EP0460118A1 (en) * 1989-03-23 1991-12-11 Mallinckrodt International Corporation Radioactive iodine- or bromine labelled piperidine compound as well as method of preparing same and composition comprising said compound
DE4138756A1 (de) * 1991-11-26 1993-05-27 Troponwerke Gmbh & Co Kg Kombination mit neuroprotektiver wirkung
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
DE69330823T2 (de) * 1992-02-13 2002-05-02 Merrell Pharmaceuticals Inc., Cincinnati Thiacyclische piperidinylderivate
NZ254113A (en) * 1992-07-13 1995-08-28 Janssen Pharmaceutica Nv Fused piperidine derivatives and medicaments
ATE288270T1 (de) * 1993-11-19 2005-02-15 Janssen Pharmaceutica Nv Mikroverkapselte 1,2-benzazole
ES2085234B1 (es) * 1994-02-24 1997-01-16 Vita Invest Sa Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
TW421649B (en) * 1995-01-31 2001-02-11 Janssen Pharmaceutica Nv 4-(1H-indol-1yl)-1-piperidinyl derivatives
US5753664A (en) * 1995-03-16 1998-05-19 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
EP1560814A1 (en) * 2002-11-13 2005-08-10 Synthon B.V. Process for making risperidone and intermediates therefor
WO2004094415A1 (en) * 2003-04-22 2004-11-04 Synthon B.V. Risperidone monohydrochloride
EP3106166B1 (en) 2008-02-29 2020-12-02 VM Therapeutics LLC Compounds for treating pain syndrome and other disorders
EP3406252B1 (en) 2012-02-10 2020-05-13 PTC Therapeutics, Inc. Compounds for treating spinal muscular atrophy
US9371336B2 (en) 2012-03-01 2016-06-21 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
EP2828247B1 (en) 2012-03-23 2019-01-16 PTC Therapeutics, Inc. 4h-chromen-4-one derivatives for treating spinal muscular atrophy
EP2970188A4 (en) * 2013-03-15 2016-10-19 Vm Therapeutics Llc NOVEL CRYSTALLINE FORMS
WO2015105657A1 (en) 2013-12-19 2015-07-16 Ptc Therapeutics, Inc. Methods for modulating the amount of rna transcripts
EP3310169B1 (en) 2015-05-30 2023-05-17 PTC Therapeutics, Inc. Methods for modulating rna splicing
CA3119019C (en) 2015-12-10 2024-06-11 Ptc Therapeutics, Inc. Compounds and methods for treating huntington's disease
JP2019535789A (ja) 2016-11-28 2019-12-12 ピーティーシー セラピューティクス，インコーポレーテッド Ｒｎａスプライシングを調節する方法
EP4151627A1 (en) 2017-06-05 2023-03-22 PTC Therapeutics, Inc. Compounds for treating huntington's disease
CN111372611A (zh) 2017-06-14 2020-07-03 Ptc医疗公司 修饰rna剪接的方法
CN111163838B (zh) 2017-06-28 2023-03-28 Ptc医疗公司 用于治疗亨廷顿氏病的方法
CN111182898B (zh) 2017-06-28 2024-04-16 Ptc医疗公司 用于治疗亨廷顿氏病的方法
BR112020019373A2 (pt) 2018-03-27 2020-12-29 Ptc Therapeutics, Inc. Compostos para o tratamento da doença de hutington
IL279688B2 (en) 2018-06-27 2025-01-01 Ptc Therapeutics Inc Heterocyclic and heteroaryl compounds for the treatment of Huntington's disease
WO2020005882A1 (en) 2018-06-27 2020-01-02 Ptc Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
KR20210038845A (ko) 2018-06-27 2021-04-08 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료를 위한 헤테로아릴 화합물
CA3139821A1 (en) 2019-05-13 2020-11-19 Ptc Therapeutics, Inc. Compounds for treating huntington's disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412094A (en) * 1967-06-21 1968-11-19 Searle & Co 5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
JPS5146497A (en) * 1974-10-19 1976-04-20 Masato Aiura Hobuban
JPS525795A (en) * 1975-06-28 1977-01-17 Sankyo Co Ltd Preparation of tetrahydro pyridopyrimidinone derivatives
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom

Also Published As

Publication number Publication date
NO156752C (no) 1987-11-18
GR72488B (cs) 1983-11-14
PH16530A (en) 1983-11-10
CA1163994A (en) 1984-03-20
DK159390C (da) 1991-03-04
US4342870A (en) 1982-08-03
ES8300763A1 (es) 1982-11-01
FI810956L (fi) 1981-09-29
YU81081A (en) 1983-12-31
BG36199A3 (en) 1984-09-14
PT72740B (en) 1982-11-16
AU6842981A (en) 1981-10-01
RO82508A (ro) 1983-09-26
MA19107A1 (fr) 1981-10-01
SU1068037A3 (ru) 1984-01-15
IL62494A0 (en) 1981-05-20
DK138281A (da) 1981-09-29
NZ196522A (en) 1985-10-11
NO811058L (no) 1981-09-29
IE51319B1 (en) 1986-12-10
ES500814A0 (es) 1982-11-01
EP0037265A1 (en) 1981-10-07
AU537700B2 (en) 1984-07-05
IL62494A (en) 1984-08-31
EP0037265B1 (en) 1985-01-23
DE3168433D1 (de) 1985-03-07
IE810706L (en) 1981-09-28
DK159390B (da) 1990-10-08
HU187329B (en) 1985-12-28
FI71737B (fi) 1986-10-31
NO156752B (no) 1987-08-10
CS256366B2 (en) 1988-04-15
RO82508B (ro) 1983-08-30
PT72740A (en) 1981-04-01
FI71737C (fi) 1987-02-09

Similar Documents

Publication Publication Date Title
YU81081A (en) Process for obtaining new derivatives of 3-(1-piperidinylalkyl)-4h-pyrido-1,2-a-pyrimidine-4-ones
RO83101B (ro) Procedeu de preparare a unor derivati de nicotinamida
HUT34741A (en) Process for preparing new derivatives of 1-ethyl-2,6-dimethyl-8-hydroxy-polyhydro-naphthalene
YU126281A (en) Process for obtaining new pyridoxine derivatives
PL232331A1 (en) Method of obtaining new derivatives of 6a,10 n-trans-9-beta-amino-1-hydroxyocta-hydrobenzene/o/ quinoline
PT73712A (en) Process for the production of derivatives of 2-(2-benzofuranyl)ethanolamine
YU42448B (en) Process for obtaining derivative of 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)pyridinone-2-
PL232330A1 (en) Method of obtaining new derivatives of oxazolidinodione-2,4
GR64892B (en) Method for the preparation of new derivatives of 1,3 diphenoxypropan-2-on
YU44524B (en) Process for obtaining derivatives of 3,4-dihydro-2h-benzopyrans
PL241179A1 (en) Process for preparing novel derivatives of 4a,9b-trans-hexahydro-1h-pyridoindole
PL235949A1 (en) Process for preparing derivatives of 2,3,4-trinor-1,5-inter-m-phenyleneprostacyclin
AU9141182A (en) 9-(3-(3,5-cis-dimethylpiperazino)propyl)carbazole for treatment of anxiety
PT72565A (en) Process for the preparation of phenoxy-aminopropanol derivatives
NZ197563A (en) 3-(1,2,4-triazinylthiomethyl)-3-cephem-1-sulphoxide derivatives
HU182341B (en) Process for preparing new substituted phenoxy-amino-propanol derivatives
YU163779A (en) Process for obtaining imidazolyl-ethoxy derivatives of pyrrazolo (3,4-b)-pyridine-5-methanol
YU295080A (en) Process for obtaining new derivatives of 1-xo-1h-thiazolo (3,2-a)pyrimidine-2-carboxamides
PH19848A (en) Process for the preparation of 5,6,7,7a-tetrahydro-4-thieno (3,2-c)-pyridin-2-one derivatives
PT73870A (en) Process for the preparation of 11-dodecen-1-yl derivatives
PT74114B (en) Process for the preparation of 1,2-dihydro-5-(pyridinyl)-nico- tinamide derivatives
YU250379A (en) Process for obtaining 2-amino-or 2-thio-substituted derivatives of 4,5-diphenyl-oxazole
DE3163891D1 (en) Process for the preparation of vinylphosphoric-acid derivatives
PL231451A1 (en) Process for preparing derivatives of methylquinoxaline 1,4-dioxide
PT75026B (en) Process for the preparation of 1,2,3,4,4a,9b-hexahydro-4a-piperazinylmethyl 4-dibenzofuranone or -dibenzofuranol derivatives